Boston Scientific (BSX) Cost of Revenue (2009 - 2026)

Boston Scientific's Cost of Revenue history runs 18 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 11257.14% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 139.88% YoY), while the FY2025 annual figure was $6.2 billion, up 18751.52% from the prior year.
• Cost of Revenue came in at $1.6 billion for Q1 2026 at Boston Scientific, down from $1.6 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.3 billion in Q4 2023 to a low of -$2.9 billion in Q4 2022.
• A 5-year average of $656.8 million and a median of $955.0 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue sank 398.15% in 2022 and jumped 17766.67% in 2025, its largest moves.
• Boston Scientific's Cost of Revenue stood at -$2.9 billion in 2022, then jumped by 248.72% to $4.3 billion in 2023, then plunged by 99.79% to $9.0 million in 2024, then surged by 17766.67% to $1.6 billion in 2025, then declined by 1.12% to $1.6 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $1.6 billion, $1.6 billion, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison